## Abstract ## Background and Objectives As a potential therapy for malignant glioma, we tested the phthalocyanine photosensitizer Pc 4 for: (1) rapid clearance from the vasculature, (2) specificity for glioma, and (3) tumoricidal photosensitizing capability. ## Study Design/Materials and Methods
Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin
โ Scribed by Jiang, Feng; Lilge, Lothar; Grenier, Joseph; Li, Yi; Wilson, Mark D.; Chopp, Michael
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 276 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
โฆ Synopsis
Background and objective:
Liposomes as photosensitizer carriers may enhance the photodynamic effect on tumors.
Study design/materials and methods:
To test this hypothesis, we treated u87 human glioma in rat brain with photodynamic therapy (pdt) using photofrin encapsulated in a liposome carrier or photofrin in dextrose. nontumored brain was also treated and photofrin content ratios were measured in tumor and nontumored brain.
Results:
Pdt using the liposome encapsulated photosensitizer significantly increased tumor destruction compared to pdt with photofrin in dextrose (p = 0.007), whereas no difference in tissue damage was detected in nontumored brain with or without liposome carrier. photofrin uptake was also significantly elevated in the liposome vehicle group compared to the dextrose (p < 0.05) group.
Conclusions:
Our data suggest that photofrin encapsulated in a liposome may enhance the pdt treatment of human brain tumors.
๐ SIMILAR VOLUMES
## Abstract The distribution of Photofrin II (PโII) and aluminum phthalocyanine tetrasulfonate (AIPCS~4~) in tissues of BALB/c nu/nu nude mice bearing the LOX human melanoma was measured fluorimetrically at different times after intraperitoneal injection of the drugs, 20 mg/kg body weight. The plas